Beerse, Belgium (ots/PRNewswire) - Today, Janssen-Cilag are celebrating their 50 year commitment to researching and developing innovative medicines to help improve the lives of people with mental health problems. Back in 1958, the late Dr. Paul Janssen developed one of the first anti-psychotic drugs, which proved to be a real breakthrough in the treatment of schizophrenia and hailed the onset of a new era for patients ...
Paris (ots/PRNewswire) - - VNT(TM) 3rd Generation for Diesel and New Gasoline Technologies Enable Engine Downsizing Honeywell (NYSE: HON) has announced that it is scheduled to launch turbo applications that will be fitted on over 200 small engine vehicles in the next two years. The focus on small engines reflects a market trend that sees small turbo engines ...
Basking Ridge, New Jersey (ots/PRNewswire) - - Supplemental Analysis From Four-Year, Landmark Study Finds Need for Tailored Strategies Enterprises should assess their security strategies knowing that the challenges differ significantly by industry and that a one-size-fits-all approach is rarely effective. Those are the key findings in a supplemental ...
St. Petersburg, Russia (ots/PRNewswire) - - New office provides foundation for Visteon's business development activities in Russia Visteon Corporation (NYSE: VC), a leading supplier of automotive interiors, climate, electronics and lighting systems, recently opened an office in St. Petersburg, Russia. The office, based on Nevsky Prospect, provides an ...
New York (ots/PRNewswire) - Asset Control, a world-wide leader in financial data management solutions, today announced that Germany's largest retail bank Postbank has chosen Asset Control's AC Plus financial and reference data management software. Postbank will use Asset Control to provide quality controlled pricing data to the bank's risk control department and support its Internal VaR (Value at Risk) Model for ...
Mumbai, India (ots/PRNewswire) - - Partnership With Batelco Expands Global MPLS Network Tata Communications, a leading provider of a new world of communications announced another key milestone in the global expansion of its MPLS network into the Middle East through a partnership with Bahrain Telecommunications Company (Batelco). Batelco is Bahrain's leading integrated communications provider, providing ...
London (ots/PRNewswire) - - World Contraception Day 2008 Highlights Scale and Impact of Unplanned Pregnancy Today, international sexual and reproductive health experts and successful recording artist and media personality Kelly Osbourne, call for more action to address the burgeoning problem of ...
Oxford, England (ots/PRNewswire) - - Conference to Become Annual International Event Featuring the World's Leading Thinkers and Doers Four years after its first European gathering, TED organizers today announced the return of the TEDGlobal Conference to Oxford, UK, on an annual basis. TEDGlobal 2009, the inaugural annual conference, is titled "The Substance of Things Not Seen," and will feature more than ...
Zaltbommel, The Netherlands (ots/PRNewswire) - - Landliebe Milk From Cows Raised Exclusively on Indigenous, GM-Free Feed From 1 October, Landliebe, one of Germany's best-loved and most popular dairy brands, will be selling its milk and school milk from cows raised exclusively on indigenous feed. The move to a more sustainable feed is a further reflection of ...
Ingelheim, Germany (ots/PRNewswire) - - For Healthcare Media Outside the U.S.A., Canada, and Japan - Favourable Safety and Efficacy Profile of Actilyse(R) Confirmed by ECASS 3 Study Investigating Treatment in an Extended Time Window up to 4.5 Hours After Symptom Onset First results from ECASS 3 ...
St. Peter Port, Guernsey (ots/PRNewswire) - European Capital Limited (LSE: ECAS) ("European Capital"), announced today that its subsidiary ECAS S.a.r.l. has invested euro 30 million (US$43 million) in Compagnie Europeenne de Prestations Logistiques ("CEPL"), a leading European logistics provider specialized in the outsourcing of automated multi-product order preparation ("Detailed Picking"). The investment was led ...
Leuven, Belgium (ots/PRNewswire) - - For Media Outside US and Canada - Prof. dr. Marc Decramer, Head of Pneumology of the University Hospitals Leuven, is Lead Investigator of the International UPLIFT Study Investigating Treatment of COPD Patients With tiotropium. Today he Elaborates on the Results ...
Collegeville, Pennsylvania (ots/PRNewswire) - - 85,000 Expected to Enroll in Phase 4 Study Initiated Pre-Registration - Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), today announced the initiation of the Community Acquired Pneumonia Immunization Trial in Adults a major study in adults of an investigational 13-valent conjugate vaccine designed to help prevent pneumococcal pneumonia -- the leading cause ...
Rousset, France (ots/PRNewswire) - - The First Secure System-on-Chip Awarded Common Criteria EAL4+ Certification Atmel(R) Corporation (Nasdaq: ATML) is proud to announce that the AT91S0100 and its derivatives have been granted Common Criteria certification EAL4+. This vulnerability assessment corresponds ...
Maidenhead, England (ots/PRNewswire) - - Data Represents More than 800 Patient Years of Experience Wyeth today announced study results from last week's 15th Paediatric Rheumatology European Congress (PRES) in London which highlight the safety record of etanercept (ENBREL(R)) as a continuous therapy in ...
Alzheimer's Disease International
London (ots/PRNewswire) - - Immediate Action Needed to Prepare for 100 Million Cases of Devastating Brain Disease Worldwide Expected by 2050(2) A global call for action to address the growing public health and social care emergency posed by Alzheimer's disease and related dementias to current and future ...
Vancouver, Canada (ots/PRNewswire) - Oremex Resources Inc. (TSX-V: ORM) (the "Company") would like to announce that Linda Thorstad is no longer the Chief Executive Officer of the Company. We wish her all the best in her future endeavours. On behalf of the Board of Directors Craig D. Thomas Chairman T: +1-604-688-6775 The TSX Venture Exchange has not reviewed and does not accept responsibility for the ...
HUNTINGTON BEACH, California and AMSTERDAM, Netherlands, September 18 (ots/PRNewswire) -- Agendia, a world leader in molecular cancer diagnostics, today announced that its signature breast cancer tumor recurrence test, MammaPrint(R), has been included in the updated 2008 guidelines of The Dutch Institute for ...
Maidenhead, England (ots/PRNewswire) - - New Study Results Further Support That Enbrel Effectively Clears Skin, Reduces the Prevalence of Depression and Anxiety and Improves Patients' Quality of Life Data demonstrating the significant positive impact of Enbrel (etanercept) on the quality of life of ...
Reading, England (ots/PRNewswire) - - Network Provides Foundation for Advanced IP Services Melexis, a Belgium-based semiconductor supplier for the automotive industry, has chosen a fully managed IP network from Verizon Business to enhance its global communications capabilities. Verizon Private IP will connect more than 800 Melexis employees at 12 ...
Ottawa (ots/PRNewswire) - - Serious Developers of Telephony and Speech Applications Discover the Latest Benefits, Power and Ease of use of VBVOICE With the Release of VBVoice 5.6. Pronexus Inc., a provider of standards based, IVR development Toolkits in a Visual studio .Net environment, today announced the release of VBVoice 5.6, their rapid application development environment for creating scalable and flexible ...
Calgary, Canada (ots/PRNewswire) - - TSX symbol: SBS SemBioSys Genetics Inc. (TSX:SBS), a biotechnology company developing a portfolio of therapeutic proteins for metabolic and cardiovascular diseases, today announced that it is eligible to proceed with its planned Phase I/II human clinical trial of plant-produced insulin now that the 30-day review ...
Basel, Switzerland (ots/PRNewswire) - Avastin (bevacizumab) remains the only biologic to provide overall survival (OS) benefit when used as first-line treatment in combination with chemotherapy for patients with K-Ras wild type metastatic colorectal cancer (mCRC). Avastin's strong position was confirmed ...
Collegeville, Pennsylvania (ots/PRNewswire) - - First African Nation Plans to Phase in Routine Vaccination Program Against Pneumococcal Disease for Infants and Young Children - Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), today announced that South Africa has initiated an immunization program against pneumococcal disease with PREVENAR(R) ...
Basel, Switzerland (ots/PRNewswire) - - Final Analysis of Study Confirms Benefit of Avastin(R) for Patients With Lung Cancer BASEL, Switzerland, September 15 /PRNewswire/ -- The final analysis of the Avastin in lung study (AVAiL) in patients with advanced lung cancer has shown that not only did the drug significantly slow down the disease progression, it ...
Southampton, England (ots/PRNewswire) - - Guard channel feature and low voltage operation makes device ideal for portable products Atmel(C) Corporation (Nasdaq: ATML) announced today the AT42QT1060, a touch control chip that integrates 6 channels of touch sensing with the ability to drive up to 7 low ...
Geneva (ots/PRNewswire) - - Study Highlights Underlying Reasons for why Patients are Missing Their Supplementation GENEVA, September 15 /PRNewswire/ -- New research published today at the annual meeting of the American Society for Bone and Mineral Research (ASBMR), Montréal, Canada, reveals that less ...
Stockholm (ots/PRNewswire) - - Patients Live Longer After Treatment With Capecitabine Chemotherapy Combinations Compared With Standard IV 5-FU/FA - For Non-US and Non-UK Media Only Pooled results of two phase III trials have shown that stomach and oesophageal cancer patients treated with oral chemotherapy Xeloda (capecitabine) lived approximately one ...
Basel, Switzerland (ots/PRNewswire) - - Avastin Shows Unprecedented Patient Benefits Regardless of K-Ras Status, Age and Chemotherapy Choice Avastin's (bevacizumab) essential role in the treatment of patients with metastatic colorectal cancer (mCRC), the world's second most common cancer, was ...